Patents Issued in May 11, 2017
  • Publication number: 20170128602
    Abstract: An improved mobile apparatus for sterilizing surgical trays serves as a self-contained autoclave, allowing sterilization of the interior of the apparatus and its contents. A method of sterilization using the apparatus is presented as well. By means of a dedicated transfer and storage system, the apparatus, integrable with respect to a transfer cart and a lift device, may be moved easily between a location of sterilization, a storage area, and an operating room, and more than one such apparatus may be stacked vertically for storage to enhance storage efficiency.
    Type: Application
    Filed: January 20, 2017
    Publication date: May 11, 2017
    Applicant: Progressive Sterilization, LLC
    Inventors: Barry M. SNYDER, Clarence J. SNYDER, III
  • Publication number: 20170128603
    Abstract: System and method for sterilizing a fluid. The system comprises a UV emitter (1) surrounded by an elongated element (2) arranged concentrically with respect to the UV emitter through which a coolant fluid cooling the UV emitter circulates, the elongated element (2) being surrounded by an elongated element (3) arranged concentrically with respect to the UV emitter through which the fluid to be sterilized circulates, the elongated element being (3) surrounded by an elongated element (4) arranged concentrically with respect to the UV emitter through which a coolant or heating fluid cooling or heating the fluid to be sterilized circulates. In the method for sterilizing a fluid, the fluid to be sterilized is subjected to UV radiation at a temperature ranging between ?20° C. and 160° C.
    Type: Application
    Filed: July 10, 2015
    Publication date: May 11, 2017
    Inventors: Alexandre GUAMIS ALEGRE, Fidel SALAS VICENTE, Jose SALAS VICENTE, David GUAMIS ALEGRE, Leo MORETA BUFILL
  • Publication number: 20170128604
    Abstract: A treatment apparatus and a sterilization apparatus each include a liquid reservoir portion configured to store a treatment subject liquid, a plasma generation portion configured to generate a plasma on or above a liquid surface of the treatment subject liquid, and a bubble supply portion configured to generate a bubble containing the generated plasma on or above the liquid surface and configured to supply the bubble into the treatment subject liquid. Thus, the plasma is generated on or above the liquid surface of the treatment subject liquid, and the bubble containing the generated plasma is generated and supplied into the treatment subject liquid.
    Type: Application
    Filed: January 25, 2017
    Publication date: May 11, 2017
    Applicant: NGK INSULATORS, LTD.
    Inventors: Hideki SHIMIZU, Yuichiro IMANISHI, Kazunari YAMADA, Takashi YOKOYAMA
  • Publication number: 20170128605
    Abstract: The disclosed invention relates to a two-part liquid composition for cleaning and disinfecting a substrate, comprising: (A) a disinfectant medium comprising peracetic acid; and (B) a supplemental medium comprising a non-enzymatic cleaner, a corrosion inhibitor, and a chelator. The supplemental medium (B) may further comprise an enzymatic cleaner, a surfactant, a buffer, a pH modifier, or a mixture of two or more thereof. The substrate may be a medical device, for example, an endoscope.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 11, 2017
    Inventors: Phillip P. Franciskovich, Donald G. Rosenhamer, Kathleen A. Fix
  • Publication number: 20170128606
    Abstract: Disclosed herein are devices, designs, and methods of using a device for sanitizing feet, shoes, or other surfaces in contact with the floor. The apparatus is capable of detecting the presence of a user and automatically spraying the feet of a user with a sanitizing fluid. Fluid is expelled through an elevated grate, which allows the user to stand on an elevated grate and have their feet sanitized without exposing their feet to a dirty pool of liquid.
    Type: Application
    Filed: November 1, 2016
    Publication date: May 11, 2017
    Inventor: Douglas Jackson
  • Publication number: 20170128607
    Abstract: Provided is an air ventilating and sterilizing apparatus made of copper plates. The apparatus has a plurality of copper plates to form a plurality air passages for inflowing air, and another plurality of air passages for outflowing air, through which the air flows out and in, and heat is exchanged and air is sterilized while the air flows through the air passages defined by the copper plates each having protruded areas to enlarge the entire surfaces of the plate in contact with the air to maximize the heat exchanging and sterilizing effects of the apparatus.
    Type: Application
    Filed: November 9, 2015
    Publication date: May 11, 2017
    Inventor: Kevin W. Lee
  • Publication number: 20170128608
    Abstract: An aromatic nebulizing diffuser includes an inner housing, an outer housing having an outer surface area of diamond cut facets and a center hole by which the outer housing is detachably mounted around the inner housing, a thermally conductive container mounted in the inner housing, an electric heating element mounted at the bottom side of the thermally conductive container, and an angle-adjustable electrical plug electrically coupled with the electric heating element for connection to an external power outlet and allowing adjustment of the angular position of the inner housing and the outer housing relative to the angle-adjustable electrical plug to the desired angle.
    Type: Application
    Filed: November 11, 2015
    Publication date: May 11, 2017
    Inventor: Ming Jen Hsiao
  • Publication number: 20170128609
    Abstract: An air-freshening body is held within a transparent air-permeable enclosure, and can be customized through the application of a user-customized cover. The enclosure included a tab and a pocket; the pocket houses the air-freshening body and is accessible through a slit. Eyelets are traverse through the enclosure, allowing for string to be looped through the formed holes in order to hang the enclosure from an object or support. The eyelets are arranged to allow the enclosure to be held in a vertical, horizontal, or diagonal position. To help secure the air-freshening body within the pocket, a user-actuated seal is provided. The user-actuated seal closes the slit to hold the air-freshening body in place. A desired image can be printed onto an adhesive-backed sheet. The adhesive-backed sheet can then be applies to the air-freshening body in order to serve as the user-customizable cover.
    Type: Application
    Filed: April 7, 2016
    Publication date: May 11, 2017
    Inventor: Nelson Rapoza
  • Publication number: 20170128610
    Abstract: An automatic dispensing device for volatile fluid operable to apply one or more agent to a local environment for more than 14 days. Preferred devices dispense a first agent for air freshening, and may optionally dispense a second agent, such as a drain cleaner. A workable drain cleaner is structured to permit a slow release of drain cleaning agent. A dispensing device may nonexclusively operate by evaporation of volatile fluid from a polymer or rubber-like carrier material that is infused with the volatile fluid; gravity-induced drip from a bulk supply of volatile fluid through a small orifice onto an emanator; osmotic transfer of volatile fluid from a bulk supply; gas-pump drive of volatile fluid at controlled pressure; or diffusion of volatile fluid through a wall of a container of bulk volatile fluid; and combinations thereof.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventor: Ashok V. Joshi
  • Publication number: 20170128611
    Abstract: An HVAC fluid dispersant system. The HVAC fluid dispersant system includes one or more fluid lines, the one or more fluid lines configured to allow movement of a fluid and a pump, the pump configured to move the fluid through the one or more fluid lines. The HVAC fluid dispersant system also includes a source line, the source line configured to provide the fluid to the pump and a nozzle. The nozzle is configured to receive the fluid from the one or more fluid lines, create a mist composed of the fluid and attach to a duct vent.
    Type: Application
    Filed: July 18, 2016
    Publication date: May 11, 2017
    Inventor: Xavier Rex Prax
  • Publication number: 20170128612
    Abstract: An atomiser system (2) comprising a fragrance cartridge (4) and a docking housing (6) in which the fragrance cartridge (4) is installed. The fragrance cartridge (4) comprising a bottle (8) for holding a liquid fragrance (10) therein; a wick (48) extending down into the bottle (8); a piezo disc (76) for atomising the liquid fragrance 10 received from the wick (48); and an adjustable cap (98) by which a user activates the cartridge (4), bringing the liquid fragrance (10) into contact with a certain portion of the wick (48).
    Type: Application
    Filed: January 19, 2017
    Publication date: May 11, 2017
    Inventors: Johan Van Roemburg, Derk Reilink, Petrus Henricus Aloysius Nicolaus Kuhn
  • Publication number: 20170128613
    Abstract: An apparatus for disinfecting forced air systems, having a main member including an inner surface configured for receiving the forced air systems. The main member includes a plurality of apertures disposed along the inner surface. The apparatus has at least one temperature controller and at least one air source to the controller for heated blowing air. The apertures are in communication with at least the air source, and UV light from the light source and air from the air source can at least partially pass through the inner surface.
    Type: Application
    Filed: September 16, 2016
    Publication date: May 11, 2017
    Inventor: Michael Stewart
  • Publication number: 20170128614
    Abstract: A wound dressing comprising: a water-absorbent fabric comprising at least about 10 wt. % of hydrogel-forming absorbent fibers based on the dry weight of the fabric; and an adhesion-resistant, water-permeable wound contacting surface textile layer that is substantially continuously bonded to at least one surface of said fabric. The surface textile layer may be formed by surface treatment of the fabric, or by bonding a suitable textile web to the surface of the fabric.
    Type: Application
    Filed: January 20, 2017
    Publication date: May 11, 2017
    Inventors: William PIGG, Margaret STEDMAN, Deborah ADDISON, Simon William BAYLIFF, Breda Mary CULLEN, Paul Howard LOWING, Michelle DELBONO
  • Publication number: 20170128615
    Abstract: Transposable adhesives which exhibit a change in adhesive properties upon exposure to particular stimuli or environmental factors are described. The adhesives include one or more olefin block copolymers in combination with tackifiers and process oils. The transposable adhesives may additionally include one or more polyolefin elastomers.
    Type: Application
    Filed: June 18, 2015
    Publication date: May 11, 2017
    Inventors: Eric L. BARTHOLOMEW, Kyle R. HEIMBACH, Christopher E. KOHLER, Michael ZAJACZKOWSKI
  • Publication number: 20170128616
    Abstract: The invention relates to a hemostatic composition comprising a mixture of cellulose-based short and long fibers, preparation and use thereof.
    Type: Application
    Filed: November 8, 2016
    Publication date: May 11, 2017
    Inventors: Erez ILAN, Omri Faingold, Nataly Freizus, Ronen Eavri, Dwayne Looney, Sridevi Dhanaraj, James Galloway, Walter Danker
  • Publication number: 20170128617
    Abstract: The present invention relates to a sealant formulation comprising a blend containing fibrinogen and an exogenous activator of a member of a mammalian blood clotting cascade.
    Type: Application
    Filed: November 8, 2016
    Publication date: May 11, 2017
    Inventors: Ashley DeAnglis, Anne J. Gorman
  • Publication number: 20170128618
    Abstract: The present invention is directed to a hemostatic material comprising a compacted, hemostatic aggregates of cellulosic fibers. In some aspects, the hemostatic material further includes additives, such as carboxymethyl cellulose (CMC) or other polysaccharides, calcium salts, anti-infective agents, hemostasis promoting agents, gelatin, collagen, or combinations thereof. In another aspect, the present invention is directed to a method of making the hemostatic materials described above by compacting a cellulosic-based material into hemostatic aggregates. In another aspect, the present invention is directed to a method of treating a wound by applying hemostatic materials described above onto and/or into the wound of a patient.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 11, 2017
    Inventor: Yi-Lan Wang
  • Publication number: 20170128619
    Abstract: The present invention relates to improved hemostatic compositions comprising cellulose-based fibers supplemented with compounds, preparation and use thereof.
    Type: Application
    Filed: November 8, 2016
    Publication date: May 11, 2017
    Inventors: EREZ ILAN, Omri Faingold, Nataly Freizus, Ronen Eavri, Dwayne Looney, Sridevi Dhanaraj, James Galloway, Walter Danker
  • Publication number: 20170128620
    Abstract: This invention relates to a biodegradable implant including magnesium, wherein the magnesium contains, as impurities, (i) manganese (Mn); and (ii) one selected from the group consisting of iron (Fe), nickel (Ni) and mixtures of iron (Fe) and nickel (Ni), wherein the impurities satisfy the following condition: 0<(ii)/(i)?5, and an amount of the impurities is 1 part by weight or less but exceeding 0 parts by weight based on 100 parts by weight of the magnesium, and to a method of manufacturing the same.
    Type: Application
    Filed: January 13, 2017
    Publication date: May 11, 2017
    Inventors: Ja-Kyo Koo, Hyun-Kwang Seok, Seok-Jo Yang, Yu-Chan Kim, Sung-Youn Cho, Jong-Tack Kim
  • Publication number: 20170128621
    Abstract: A hollow fiber membrane bundle configured to be used in an artificial lung and comprised of integrated hollow fiber membranes 31 has hollow portions through which a fluid passes. The hollow fiber membrane bundle is shaped as a cylinder body. In addition, the hollow fiber membrane 31 is tilted with respect to a central axis O of the cylinder body, is wound around the central axis O of the cylinder body, and satisfies the following conditions. An inner diameter ?d1 of the hollow fiber membrane 31 is equal to or smaller than 150 ?m, a tilt angle ? with respect to the central axis O of the cylinder body of the hollow fiber membrane 31 is equal to or smaller than 60°, and a ratio ?D1/L of an outer diameter ?D1 of the cylinder body to a length L of the cylinder body is equal to or greater than 0.4.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Inventor: Eisuke Sasaki
  • Publication number: 20170128622
    Abstract: Materials and methods for bone void filling are provided. A peptide comprising between about 7 amino acids and about 32 amino acids in a solution may be introduced to a target site. The peptide may undergo self-organization under physiological conditions and/or in the presence of a cation.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 11, 2017
    Inventors: Lisa Spirio, Eun Seok Gil
  • Publication number: 20170128623
    Abstract: The present disclosure relates to in situ tissue engineering, more specifically in situ vascular tissue engineering with the aim of providing a tissue structure which can be used e.g. as a substitute blood vessel or as a blood vessel functioning as cannulation site in hemodialysis. In particular, the disclosure involves tissue structure formation around a subcutaneously implanted synthetic rod. In addition, the disclosure involves a method for producing said synthetic rod.
    Type: Application
    Filed: June 16, 2015
    Publication date: May 11, 2017
    Inventors: Joris Ivo Rotmans, Tonia Caroline Rothuizen, Lorenzo Moroni, Clemens Antoni Van Blitterswijk, Febriyani Fiain Rochel Damanik, Tom Lavrijsen, Martijn Antonius Johannes Cox, Antonius Johannes Rabelink
  • Publication number: 20170128624
    Abstract: The subject invention pertains to materials and methods for processing tissue to produce a natural, acellular replacement tissue that is immunocompatible with a recipient. According to the subject invention, harvested tissue is subjected to wash solutions wherein only amphoteric detergent(s) are used (e.g., anionic detergents are excluded). Following extraction by amphoteric detergent(s), the tissue is washed with a buffer system to facilitate the clearance of cellular components and detergent. In one embodiment, the subject invention pertains to a replacement tissue that is a nerve graft that supports axonal regeneration, guides axons toward the distal nerve end and/or is immunologically tolerated. Preferably, the nerve graft retains essential extracellular matrix scaffolding as well as biological components that promote nerve regeneration through the nerve graft.
    Type: Application
    Filed: January 25, 2017
    Publication date: May 11, 2017
    Inventor: David F. MUIR
  • Publication number: 20170128625
    Abstract: Provided herein are organoids comprising decellularized placental vascular scaffold comprising, or consisting of, a decellularized placental vascular scaffold, and methods of making and using the same.
    Type: Application
    Filed: June 15, 2016
    Publication date: May 11, 2017
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Mohit B. Bhatia, Robert J. Hariri, Wolfgang Hofgartner, Jia-Lun Wang, Qian Ye
  • Publication number: 20170128626
    Abstract: An uncoated polymeric liner for a medical joint implant constructed to be engaged in between a head (or a top plate) and a stem (or a base plate) of said medical joint implant. The uncoated polymeric liner is prepared from a polymeric matrix comprising a polymeric material and at least one metal chalcogenides or dichalcogenides nanoparticle which is distributed within said polymeric matrix.
    Type: Application
    Filed: January 18, 2017
    Publication date: May 11, 2017
    Inventor: Ronen SHAVIT
  • Publication number: 20170128627
    Abstract: Aporous composite fibrous scaffold for repair or regeneration of bone is disclosed. The scaffold comprises a first biopolymer forming a porous matrix and a second biopolymer forming fiber reinforcement. The biocompatible scaffold is configured to maintain balance between porosity and mechanical strength which could aid cellular infiltration and bone tissue regeneration. A method of preparing the porous composite scaffold is also disclosed.
    Type: Application
    Filed: November 2, 2016
    Publication date: May 11, 2017
    Applicant: Amrita Vishwa Vidyapeetham
    Inventors: Manitha B. NAIR, Deepthy Menon, Shantikumar Nair
  • Publication number: 20170128628
    Abstract: Described are packaged, sterile medical graft products containing controlled levels of a growth factor such as Fibroblast Growth Factor-2 (FGF-2). Also described are methods of manufacturing medical graft products wherein processing, including sterilization, is controlled and monitored to provide medical graft products having modulated, known levels of a extracellular matrix factor, such as a growth factor, e.g. FGF-2. Preferred graft materials are extracellular matrix materials isolated from human or animal donors, particularly submucosa-containing extracellular matrix materials. Further described are ECM compositions that are or are useful for preparing gels, and related methods for preparation and use.
    Type: Application
    Filed: October 25, 2016
    Publication date: May 11, 2017
    Inventors: Michael C. Hiles, Jason P. Hodde, David M.J. Ernst, Lal Ninan
  • Publication number: 20170128629
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: May 17, 2016
    Publication date: May 11, 2017
    Inventor: Frank R. Prosl
  • Publication number: 20170128630
    Abstract: The present invention relates generally to specially designed magnesium-aluminum (“Mg—Al”) alloys and medical uses thereof in a hemodynamic environment, and, more particularly to devices for sealing an opening formed through biological tissue (such as blood vessels) made from such specially designed magnesium-aluminum alloys.
    Type: Application
    Filed: October 9, 2015
    Publication date: May 11, 2017
    Applicant: TRANSLUMINAL TECHNOLOGIES, LLC
    Inventors: Stephen Green, Rudolph Buchheit
  • Publication number: 20170128631
    Abstract: A plated object wherein the plating material has biocidal properties. The plated object can be used in a food preparation or medical care facility. The plating material includes approximately 55% copper (plus or minus 10%), 35% tin (plus or minus 10%) and 10% zinc (plus or minus 5%) by weight. In another embodiment, the plating material includes approximately 45% copper, 45% tin and 10% zinc. A method of depositing the plating material is also disclosed.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Inventor: Jeffrey D. Smith
  • Publication number: 20170128632
    Abstract: An implantable medical device for controlling the rate of release of a therapeutic agent is provided. The implantable medical device features at least one non-bioresorbable polymer, and/or at least one bioresorbable polymer, where the bioresorbable polymers have different degrees of hydrophilicity. Further, the implantable medical device incorporates at least one therapeutic agent contained in said at least one of non-bioresorbable polymer and/or said at least one of bioresorbable polymer. Preferably, the therapeutic agent is at least one anesthetic.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 11, 2017
    Inventor: William Charles McJames, II
  • Publication number: 20170128633
    Abstract: The present application relates to bioactive implants, methods of making bioactive implants, and methods of using bioactive implants to treat or repair a bone defect or a cartilage defect. In an aspect, the present application relates to compositions comprising bone microparticles in a solution, wherein the compositions harden upon desiccation into bioactive implants. In an aspect, the present application relates to compositions comprising cartilage microparticles in a solution, wherein the compositions harden upon desiccation into bioactive implants. In an aspect, disclosed herein are methods of making and using the disclosed compositions comprising bone microparticles and the disclosed composition comprising cartilage microparticles. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 11, 2017
    Inventor: Theodore Malinin
  • Publication number: 20170128634
    Abstract: The present application relates to bioactive implants, methods of making bioactive implants, and methods of using bioactive implants to treat or repair a bone defect or a cartilage defect. In an aspect, the present application relates to compositions comprising bone microparticles in a solution, wherein the compositions harden upon desiccation into bioactive implants. In an aspect, the present application relates to compositions comprising cartilage microparticles in a solution, wherein the compositions harden upon desiccation into bioactive implants. In an aspect, disclosed herein are methods of making and using the disclosed compositions comprising bone microparticles and the disclosed composition comprising cartilage microparticles. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 11, 2017
    Inventor: Theodore Malinin
  • Publication number: 20170128635
    Abstract: An improvement in drug-eluting stents, and method of their making, are disclosed. The surface of a metal stent is roughened to have a surface roughness of at least about 20 ?in (0.5 ?m) and a surface roughness range of between about 300-700 ?in (7.5-17.5 ?m). The roughened stent surface is covered with a polymer-free coating of a limus drug, to a coating thickness greater than the range of surface roughness of the roughened stent surface.
    Type: Application
    Filed: January 13, 2017
    Publication date: May 11, 2017
    Inventors: Douglas R. Savage, John E. Shulze, Ronald E. Betts, Sepehr Fariabi, Shih-Horng Su
  • Publication number: 20170128636
    Abstract: The disclosure relates to a medical material including a copolymer having a repeating unit (A) represented by the following formula (1): wherein R11 is a hydrogen atom or a methyl group, Z is an oxygen atom or —NH—, R12 is a C1-6 alkylene group, R13 and R14 are each independently a C1-4 alkyl group, and R15 is a C1-6 alkylene group, and a repeating unit (B) represented by the following formula (2): wherein R21 is a hydrogen atom or a methyl group, R22 is a C1-6 alkylene group, and R23 is a C1-4 alkyl group. The repeating unit (A) is contained in a proportion of 0.6 to 7 mol % based on all the structural units of the copolymer. The disclosure makes it possible to provide a medical material and a medical device, which exhibit excellent antithrombogenicity even when used under severe conditions prone to thrombus formation.
    Type: Application
    Filed: August 23, 2016
    Publication date: May 11, 2017
    Applicant: TERUMO KABUSHIKI KAISHA
    Inventors: Takao ANZAI, Kaori NISHIDA
  • Publication number: 20170128637
    Abstract: A device for aspirating and transferring blood during a surgical operation has a first chamber and a second chamber for collecting and transferring the aspirated blood, and an electronically controlled valve unit for connecting the chambers to a vacuum source. The valve unit establishes this connection alternately between the first chamber and the vacuum source and the second chamber and the vacuum source, such that the first or second chamber connected to the vacuum source can be filled with aspirated blood, and the other, second or first chamber can be emptied at the same time. The valve unit is connected to the first and second chamber and permits a pressure increase in the first or second chamber to be emptied. This device allows blood to be efficiently collected and transferred during operations in a way that is gentle on the blood.
    Type: Application
    Filed: June 18, 2015
    Publication date: May 11, 2017
    Inventors: Robin Mann, Martin Walti
  • Publication number: 20170128638
    Abstract: A medical suction pump for aspiration of bodily fluid has a suction pump housing, a fluid collection container held releasably on the housing, and at least one filling level sensor. The fluid collection container has a first side wall and at least one further side wall which together delimit at least one interior space for receiving the aspirated fluid. The at least one filling level sensor extends at least approximately parallel to the first side wall over at least a partial area of the fillable height of the interior space. The first side wall is place at least in part, and the cross section of the at least one interior space tapers vertically from the top downwards, at least over a partial area of the fillable height.
    Type: Application
    Filed: June 18, 2015
    Publication date: May 11, 2017
    Inventors: Charles Giezendanner, Martin Melzer, Martin Walti
  • Publication number: 20170128639
    Abstract: A method for removing excess fluid from a patient with hemodilution is provided. The method includes: deploying a urinary tract catheter into the patient such that flow of urine from the ureter and/or kidney is transported within a drainage lumen of the catheter; applying negative pressure to the ureter and/or kidney through the drainage lumen of the catheter to extract urine from the patient; periodically measuring a hematocrit value of the patient; and if the measured hematocrit value is greater than a predetermined threshold value, ceasing the application of the negative pressure to the ureter and/or kidney. A system for removing excess fluid from a patient with hemodilution including a ureteral catheter and a pump is also provided.
    Type: Application
    Filed: January 20, 2017
    Publication date: May 11, 2017
    Inventors: John R. Erbey, II, Jacob L. Upperco, Michael Allen Fisher, Patrick William Strane, Lance Michael Black, David E. Orr
  • Publication number: 20170128640
    Abstract: This device is used to clear clots and blockages from chest drainage tubes. This invention relates to patient safety after open-heart surgical procedures, wherein postoperative drainage from the surgical site is a critical component of care. Blocked drainage tubes can cause dangerous retained blood complications, most notably, cardiac tamponade, which essentially smothers the heart.
    Type: Application
    Filed: August 26, 2016
    Publication date: May 11, 2017
    Applicant: Epic Medical Concepts & Innovations, Inc.
    Inventor: James R. Lucas
  • Publication number: 20170128641
    Abstract: Methods and devices for treatment of damaged tissue are disclosed, including treatment of wounds by employing non-electrically powered, reduced pressure therapy devices. The devices are capable of generating a substantially constant reduced pressure with low tolerance for pressure fluctuations. Also disclosed herein are reduced pressure therapy systems that comprise an alarm system to detect the depleted state of the suction device and provide an alert to the patient and/or practitioner.
    Type: Application
    Filed: January 19, 2017
    Publication date: May 11, 2017
    Inventors: Dean HU, Thomas YORKEY, Evan ANDERSON, Kenneth WU, Tony COXUM
  • Publication number: 20170128642
    Abstract: A wound therapy device which may include a gasket distally spaced from an absorptive pad and an edge of a backing material. The device may also include an adaptor, a tube portion with a connector located distally from a port hole in the backing material, and at least one viewing portal disposed over the absorptive material allowing the absorptive material to be seen from the second side of the backing material. Also, a method of determining a saturation level of such a device.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventor: John Buan
  • Publication number: 20170128643
    Abstract: A blood bag system includes: a first bag in which blood containing multiple components is stored; a second bag in which a relative medium-density component is stored; a third bag in which a relative low-density component is stored; a first tube through which the relative low-density component and the relative medium-density component are transported from the first bag to the second bag; and a second tube through which the relative low-density component is transported from the first bag to the third bag. A blood treatment method involves: centrifuging blood containing multiple components in a first bag, transporting a low-density component from the first bag to a third bag through a first tube and transporting a relative medium-density component from the first bag to the second bag through the first tube.
    Type: Application
    Filed: January 19, 2017
    Publication date: May 11, 2017
    Applicant: TERUMO KABUSHIKI KAISHA
    Inventors: Makoto HIRABUKI, Masayoshi HIGASHI
  • Publication number: 20170128644
    Abstract: A cardiac pump includes a plain bearing assembly having a first plain bearing portion that is coupled to a cardiac pump rotor and a second plain bearing portion that is coupled to a cardiac pump housing. The plain bearing assembly is configured to rotatably support the cardiac pump rotor within the cardiac pump housing in at least an axial direction of the cardiac pump rotor. A magnetic bearing assembly includes a first magnetic bearing portion that is coupled to the cardiac pump rotor and a second magnetic bearing portion that is coupled to the cardiac pump housing. The magnetic bearing assembly is configured to rotatably support the cardiac pump rotor within the cardiac pump housing in a radial direction of the cardiac pump rotor and bias the cardiac pump rotor in the axial direction such that the magnetic bearing assembly provides a preload force to preload the plain bearing assembly.
    Type: Application
    Filed: June 9, 2015
    Publication date: May 11, 2017
    Applicant: Calon Cardio-Technology Ltd.
    Inventor: Graham Foster
  • Publication number: 20170128645
    Abstract: In order to produce a pulsatile blood flow pattern that includes time periods of relatively high blood flow rates and time periods of relatively low blood flow rates, the operating speed of a blood pump can be selectively controlled to produce an operating speed pattern that includes time periods of relatively high rotation speeds and periods of relatively low rotation speeds. For example, the blood pump is rotated at a first speed for a first period of time. The speed of the blood pump is then decreased from the first speed to a second speed and is operated at the second speed for a second amount of time. The speed of the blood pump is then decreased to a third speed for a third amount of time. If desired, the operating speed pattern can be repeated to continue the pulsatile blood flow pattern.
    Type: Application
    Filed: July 27, 2016
    Publication date: May 11, 2017
    Inventor: Kevin Bourque
  • Publication number: 20170128646
    Abstract: Methods and systems are provided for determining an outlet pressure prevailing at an outlet of a heart assist system. An inlet pressure which prevails at an inlet of the heart assist system may be determined. A pressure difference between the inlet and the outlet of the heart assist system may be determined. The outlet pressure may be determined from the inlet pressure and the pressure difference.
    Type: Application
    Filed: July 1, 2015
    Publication date: May 11, 2017
    Inventor: Dominik Karch
  • Publication number: 20170128647
    Abstract: One aspect of an intravascular ventricular assist device is an implantable blood pump where the pump includes a housing defining a bore having an axis, one or more rotors disposed within the bore, each rotor including a plurality of magnetic poles, and one or more stators surrounding the bore for providing a magnetic field within the bore to induce rotation of each of the one or more rotors. Another aspect of the invention includes methods of providing cardiac assistance to a mammalian subject as, for example, a human. Further aspects of the invention include rotor bodies having helical channels formed longitudinally along the length of the body of the rotor where each helical channel is formed between peripheral support surface areas facing radially outwardly and extending generally in circumferential directions around the rotational axis of the rotor.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Inventors: Jeffrey A. LaRose, Charles R. Shambaugh, Daniel G. White, Richard A. Marquis, Stephen A. White, Kartikeyan Trichi
  • Publication number: 20170128648
    Abstract: A medical device includes: at least one input device; at least one output device; at least one operating component; and a control unit. The control unit has data access to at least one file pertaining to the medical device, wherein text passages or graphics of the at least one file pertaining to an operating component are selectable. The control unit is configured to, after selection of a text passage or a graphic, cause at least one operating parameter of the operating component and/or at least one output variable that is created by the operating component to be read out as output, and/or facilitate input of an adjustable operating parameter for the operating component.
    Type: Application
    Filed: October 17, 2016
    Publication date: May 11, 2017
    Inventors: Jan-Willem Appel, Jürgen Klewinghaus, Stefan Rudolph, Alexander Schrörs, Georg Verch, Stefan Wittzack
  • Publication number: 20170128649
    Abstract: Treatment of cardiac tissue via an implantable heart treatment device is described. A device embodiment includes, but is not limited to, a substrate configured for implantation within a body; an electromagnetic signal generator coupled to the substrate and configured to generate one or more electric signals configured to stimulate one or more tissues of a heart; and an oxygenator coupled to the substrate and configured to supply one or more oxygenated molecules to one or more tissues of the heart, the oxygenator including a blood inlet portion, a blood outlet portion, and an oxygen exchange portion positioned between the blood inlet portion and the blood outlet portion, the oxygen exchange portion including a high surface area oxygen exchanger configured to transfer one or more oxygenated molecules from the high surface area oxygen exchanger to blood passing from the blood inlet portion to the blood outlet portion.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventors: Roderick A. Hyde, Edward K.Y. Jung, Eric C. Leuthardt, Gary L. McKnight, Lowell L. Wood, JR.
  • Publication number: 20170128650
    Abstract: Treatment of cardiac tissue via an implantable heart treatment device is described. A device embodiment includes, but is not limited to, a substrate; an electromagnetic signal generator configured to generate one or more electric signals configured to stimulate one or more tissues of a heart; a metabolic molecule supply device configured to supply one or more metabolic molecules to one or more tissues of the heart; and control circuitry operably coupled to the electromagnetic signal generator and the metabolic molecule supply device, the control circuitry configured to generate one or more control signals according to at least a first control protocol and a second control protocol, dependent upon a status of a ventricular fibrillation event of the heart.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventors: Roderick A. Hyde, Edward K.Y. Jung, Eric C. Leuthardt, Gary L. McKnight, Lowell L. Wood, JR.
  • Publication number: 20170128651
    Abstract: Treatment of cardiac tissue via an implantable heart treatment device is described. A device embodiment includes, but is not limited to, a substrate configured for implantation within a body; an electromagnetic signal generator coupled to the substrate and configured to generate one or more electric signals configured to stimulate one or more tissues of a heart within the body; and an energy-carrier molecule delivery device coupled to the substrate and configured to supply one or more non-oxygen cellular energy sources to one or more tissues of the heart within the body.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventors: Roderick A. Hyde, Edward K.Y. Jung, Eric C. Leuthardt, Gary L. McKnight, Lowell L. Wood, Jr.